Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-19

Clinical Trial Update: Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated adding Amlodipine or Chlorthalidone to Valturna versus Valturna alone in patients with stage 2 hypertension and diabetes; the study wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Chlorthalidone (chlorthalidone)
  • Valturna (valsartan/amlodipine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension, Stage 2 Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2013-03-19